<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Breakthrough T1D</provider_name><provider_url>https://breakthrought1d.eu/nl</provider_url><author_name>ylt-admin</author_name><author_url>https://breakthrought1d.eu/nl/nieuws/author/ylt-admin/</author_url><title>Nieuwe medicijnen - Breakthrough T1D</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="t7E2AsplE8"&gt;&lt;a href="https://breakthrought1d.eu/nl/behandelen/nieuwe-medicijnen/"&gt;Nieuwe medicijnen&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://breakthrought1d.eu/nl/behandelen/nieuwe-medicijnen/embed/#?secret=t7E2AsplE8" width="600" height="338" title="&#x201C;Nieuwe medicijnen&#x201D; &#x2014; Breakthrough T1D" data-secret="t7E2AsplE8" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script type="text/javascript"&gt;
/* &lt;![CDATA[ */
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://breakthrought1d.eu/nl/wp-includes/js/wp-embed.min.js
/* ]]&gt; */
&lt;/script&gt;
</html><description>Snellere insulinesoorten Sinds 1922 worden mensen met type 1 diabetes behandeld met insuline. In de afgelopen eeuw verbeterden wetenschappers deze insuline. Dierlijke insuline werd vervangen door humane insulinesoorten. Onderzoekers kijken met steun van Breakthrough T1D hoe ze deze insulinesoorten beter af kunnen stemmen op mensen met type 1 diabetes. Het lichaam van iemand zonder type [&hellip;]</description></oembed>
